Congress has decided to provide $24M a year for 5 years to establish a new program for Therapeutics for Rare and Neglected Diseases. TRND will be a part of the NIH. It is primarily designed to help drugs cross the “valley of death” from basic discovery to industry investment. It is not yet clear what diseases the TRND will focus on, but ALS would be a good candidate.
Click here to read this article.Share this: